Skip to main content

Table 1 Characteristics of patients with a minimum of 1, 3, and 5 years of follow up time

From: Adapted time-varying covariates Cox model for predicting future cirrhosis development performs well in a large hepatitis C cohort

 

1-year minimum (n = 146,182)

3-year minimum (n = 110,559)

5-year minimum (n = 84,189)

All (n = 182,772)

Age (years), mean (SD)

52.5 (8.28)

52.4 (8.08)

52.2 (7.75)

52.4 (8.32)

Male, n (%)

141,663 (96.9%)

107,012 (96.8%)

81,449 (96.7%)

177,270 (97.0%)

Race, n (%)

    

Black

51,206 (35.0%)

40,445 (36.6%)

32,007 (38.0%)

63,017 (34.5%)

White

74,948 (51.3%)

56,817 (51.4%)

42,834 (50.9%)

93,240 (51.0%)

Hispanic

6646 (4.5%)

4906 (4.4%)

3639 (4.3%)

8414 (4.6%)

Other

2561 (1.8%)

1913 (1.7%)

1427 (1.7%)

3212 (1.8%)

Missing

10,821 (7.4%)

6478 (5.9%)

4282 (5.1%)

14,889 (8.1%)

BMI, mean (SD)

27.5 (5.24)

27.5 (5.23)

27.6 (5.23)

27.4 (5.24)

History of alcohol use disorder

73,961 (50.6%)

56,466 (51.1%)

43,473 (51.6%)

93,045 (50.9%)

History of substance use disorder

75,350 (51.5%)

58,339 (52.8%)

45,478 (54.0%)

94,167 (51.5%)

Diabetes mellitus

47,846 (32.7%)

37,977 (34.3%)

30,125 (35.8%)

57,889 (31.7%)

Human immunodeficiency virus

4085 (2.8%)

3373 (3.1%)

2738 (3.3%)

4863 (2.7%)

Received antiviral treatment*, n (%)

75,820 (51.9%)

61,435 (55.6%)

49,338 (58.6%)

95,630 (52.3%)

SVR, n (%)

69,475 (47.5%)

56,534 (51.1%)

45,629 (54.2%)

76,854 (42.0%)

Baseline laboratory values, mean (SD)

    

APRI

0.648 (0.692)

0.609 (0.510)

0.585 (0.473)

0.668 (0.686)

Albumin (g/dL)

3.99 (0.447)

4.01 (0.437)

4.01 (0.430)

3.98 (0.461)

Alanine aminotransferase (U/L)

65.8 (53.6)

64.2 (52.0)

63.3 (50.7)

67.1 (55.9)

Aspartate aminotransferase (U/L)

51.5 (33.4)

49.7 (31.6)

48.6 (30.6)

52.5 (34.3)

Total bilirubin (mg/dL)

0.706 (0.407)

0.696 (0.373)

0.691 (0.369)

0.716 (0.472)

Blood urea nitrogen (mmol/L)

14.1 (7.15)

14.0 (6.84)

14.0 (6.61)

14.1 (7.44)

Chloride (mmol/L)

103 (3.57)

103 (3.52)

103 (3.51)

103 (3.60)

Creatinine (mg/dL)

1.04 (0.743)

1.04 (0.713)

1.04 (0.686)

1.05 (0.769)

Glucose (mg/dL)

115 (59.6)

115 (59.5)

115 (59.6)

115 (59.5)

Hemoglobin (g/dL)

14.9 (1.59)

15.0 (1.56)

15.0 (1.54)

14.9 (1.62)

INR

1.05 (0.282)

1.05 (0.287)

1.05 (0.278)

1.06 (0.282)

Platelet (1000/µL)

229 (72.5)

231 (71.3)

233 (70.7)

228 (73.7)

Potassium (mEq/dL)

4.23 (0.441)

4.23 (0.439)

4.23 (0.438)

4.22 (0.444)

Total protein (g/dL)

7.55 (0.670)

7.55 (0.664)

7.55 (0.661)

7.55 (0.678)

Sodium (mEq/dL)

139 (3.11)

139 (3.09)

139 (3.08)

139 (3.14)

White blood cell count (1000/µL)

7.19 (2.56)

7.20 (2.54)

7.20 (2.54)

7.20 (2.62)

  1. *Treated during 2000–2015. Does not include patients treated after 2015